In the present study, we found evidence of early changes in the structure of blood vessels in children with SRNS, as they had thicker CIMT, compared to the controls. This finding is similar to the results reported by Hooman et al. who demonstrated increased cIMT in children with idiopathic nephrotic syndrome (both steroid-sensitive and -resistant), associated with the duration of disease and hypertension (
10).
Furthermore, Candan et al. reported changes in cIMT, pulse wave velocity, and left ventricular mass in children with SRNS, which were significantly correlated with proteinuria (
11), leading to cardiovascular complications. The main reason is probably multifactorial, including the associated hyperlipidemia (
12), hypertension, tendency to thrombosis (
13,
14), and use of immunosuppressive medications. SRNS is also associated with increased endothelial markers, such as soluble thrombomodulin, plasminogen activator inhibitor-1, tissue plasminogen activator, and von-Willebrand factor (
15), all of which are related to endothelial activation.
Despite achieving remission in the majority of cases during the present research, the study group had an atherogenic lipid profile with high cholesterol level. Nevertheless, the effect of long exposure to disease could persist even after remission, as shown in previous studies (
10). We excluded children with stage 2 CKD (or above) in order to avoid the confounding effect of impaired renal function in the cardiovascular system (
16).
Overall, use of lipid-lowering agents in children with SRNS is limited, and only few reports are available (
17). However, given the reported association between increased VLDL level and subclinical CVD in children with SRNS (
10), such treatments could be indicated; in fact, more comprehensive studies are required in this area.